1
|
Yamazaki H, Kobayashi T, Hiranai S, Sawahata M, Toida N, Sato F, Hinata J, Terakado M, Ishita K, Ikeda R, Shinya T, Yajima S, Kajiwara K. Evaluation of a newly developed low reflection dummy load for high power millimeter waves. Fusion Engineering and Design 2023. [DOI: 10.1016/j.fusengdes.2023.113684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/03/2023]
|
2
|
Kobayashi T, Yamazaki H, Hiranai S, Sawahata M, Terakado M, Ishita K, Hinata J, Sato F, Wada K, Ikeda R, Shinya T, Yajima S, Kajiwara K, Takahashi K, Moriyama S. High power experiment and heat load evaluation of transmission line for the ECH/CD system in JT-60SA. Fusion Engineering and Design 2022. [DOI: 10.1016/j.fusengdes.2022.113009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
3
|
Yajima S, Kobayashi T, Kajiwara K, Ikeda R, Takahashi K. Development of a new analytic method for miter bend polarizer on ECW transmission line. Fusion Engineering and Design 2021. [DOI: 10.1016/j.fusengdes.2021.112487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
4
|
Yajima S, Kajiwara K, Isozaki M, Kobayashi N, Ikeda R, Kobayashi T, Shinya T, Yamazaki H, Takahashi K. Estimation of RF power absorption and stray distribution at plasma breakdown based on the design of ITER ECH&CD equatorial launcher. Fusion Engineering and Design 2021. [DOI: 10.1016/j.fusengdes.2021.112470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
5
|
Takashima Y, Kawaguchi A, Fukai J, Iwadate Y, Kajiwara K, Hondoh H, Yamanaka R. Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma. PLoS One 2021; 16:e0251272. [PMID: 34166375 PMCID: PMC8224980 DOI: 10.1371/journal.pone.0251272] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2021] [Accepted: 04/23/2021] [Indexed: 11/18/2022] Open
Abstract
Dysregulation of cell morphology and cell-cell interaction results in cancer cell growth, migration, invasion, and metastasis. Besides, a balance between the extracellular matrix (ECM) and matrix metalloprotease (MMP) is required for cancer cell morphology and angiogenesis. Here, we determined gene signatures associated with the morphology and microenvironment of primary central nervous system lymphoma (PCNSL) to enable prognosis prediction. Next-generation sequencing (NGS) on 31 PCNSL samples revealed gene signatures as follows: ACTA2, ACTR10, CAPG, CORO1C, KRT17, and PALLD in cytoskeleton, CDH5, CLSTN1, ITGA10, ITGAX, ITGB7, ITGA8, FAT4, ITGAE, CDH10, ITGAM, ITGB6, and CDH18 in adhesion, COL8A2, FBN1, LAMB3, and LAMA2 in ECM, ADAM22, ADAM28, MMP11, and MMP24 in MMP. Prognosis prediction formulas with the gene expression values and the Cox regression model clearly divided survival curves of the subgroups in each status. Furthermore, collagen genes contributed to gene network formation in glasso, suggesting that the ECM balance controls the PCNSL microenvironment. Finally, the comprehensive balance of morphology and microenvironment enabled prognosis prediction by a combinatorial expression of 8 representative genes, including KRT17, CDH10, CDH18, COL8A2, ADAM22, ADAM28, MMP11, and MMP24. Besides, these genes could also diagnose PCNSL cell types with MTX resistances in vitro. These results would not only facilitate the understanding of biology of PCNSL but also consider targeting pathways for anti-cancer treatment in personalized precision medicine in PCNSL.
Collapse
Affiliation(s)
- Yasuo Takashima
- Osaka Iseikai Clinic for Cancer Therapy, Iseikai Holonics Group, Osaka, Japan
- Laboratory of Molecular Target Therapy for Cancer, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Atsushi Kawaguchi
- Faculty of Medicine, Center for Comprehensive Community Medicine, Saga University, Saga, Japan
| | - Junya Fukai
- Department of Neurological Surgery, Wakayama Medical University School of Medicine, Wakayama, Japan
| | - Yasuo Iwadate
- Department of Neurosurgery, Graduate School of Medical Sciences, Chiba University, Chiba, Japan
| | - Koji Kajiwara
- Department of Neurosurgery, Graduate School of Medical Sciences, Yamaguchi University, Ube, Yamaguchi, Japan
| | - Hiroaki Hondoh
- Department of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan
| | - Ryuya Yamanaka
- Osaka Iseikai Clinic for Cancer Therapy, Iseikai Holonics Group, Osaka, Japan
- Laboratory of Molecular Target Therapy for Cancer, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
- * E-mail:
| |
Collapse
|
6
|
Akitsu TK, Nakaji T, Kobayashi H, Okano T, Honda Y, Bayarsaikhan U, Terigele, Hayashi M, Hiura T, Ide R, Igarashi S, Kajiwara K, Kumikawa S, Matsuoka Y, Nakano T, Nakano T, Okuda A, Sato T, Tachiiri K, Takahashi Y, Uchida J, Nasahara KN. Large‐scale ecological field data for satellite validation in deciduous forests and grasslands. Ecol Res 2020. [DOI: 10.1111/1440-1703.12155] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
| | - Tatsuro Nakaji
- Uryu Experimental Forest, Field Science Center for Northern Biosphere Hokkaido University Horokanai Japan
| | | | - Tetsuo Okano
- Faculty of Agriculture Shinshu University Minami Minowa Japan
| | - Yoshiaki Honda
- Center for Environmental Remote Sensing Chiba University Chiba Japan
| | - Undrakh Bayarsaikhan
- Graduate School of Life and Environmental Science University of Tsukuba Tsukuba Japan
| | - Terigele
- Graduate School of Life and Environmental Science University of Tsukuba Tsukuba Japan
| | - Masato Hayashi
- Earth Observation Research Center Japan Aerospace Exploration Agency Tokyo Japan
| | - Tsutom Hiura
- Graduate School of Agricultural and Life Sciences The University of Tokyo Tokyo Japan
| | - Reiko Ide
- Center for Global Environmental Research National Institute for Environmental Studies Tsukuba Japan
| | - Susumu Igarashi
- Tomakomai Experimental Forest, Field Science Center for Northern Biosphere Hokkaido University Tomakomai Japan
| | - Koji Kajiwara
- Center for Environmental Remote Sensing Chiba University Chiba Japan
| | - Syoji Kumikawa
- Tomakomai Experimental Forest, Field Science Center for Northern Biosphere Hokkaido University Tomakomai Japan
| | - Yuuichi Matsuoka
- Tomakomai Experimental Forest, Field Science Center for Northern Biosphere Hokkaido University Tomakomai Japan
| | | | | | - Atsushi Okuda
- Tomakomai Experimental Forest, Field Science Center for Northern Biosphere Hokkaido University Tomakomai Japan
| | - Tomoaki Sato
- Tomakomai Experimental Forest, Field Science Center for Northern Biosphere Hokkaido University Tomakomai Japan
| | - Kaoru Tachiiri
- Research Institute for Global Change Japan Agency for Marine‐Earth Science and Technology Yokohama Japan
| | - Yoshiyuki Takahashi
- Center for Global Environmental Research National Institute for Environmental Studies Tsukuba Japan
| | - Jiro Uchida
- Tomakomai Experimental Forest, Field Science Center for Northern Biosphere Hokkaido University Tomakomai Japan
| | | |
Collapse
|
7
|
Kondo K, Hara K, Keiichi O, Abe S, Kajiwara K. Detection of the Metastable Ice Phase during Water Crystallization. Cryo Letters 2020; 41:291-296. [PMID: 33988667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
BACKGROUND Under atmospheric pressure, the identifiable phases of ice crystals are hexagonal (stable) and cubic (metastable). OBJECTIVE This study aimed to test the hypothesis that water crystallizes into the cubic phase at the beginning and then changes to the hexagonal phase. MATERIALS AND METHODS Aqueous solutions of 40% (w/w) and 50% (w/w) glucose, and 40% (w/w) ammonium hydrogen sulfate, as well as emulsified water, were investigated. RESULTS The cubic-to-hexagonal ice phase transition was detected in 40% (w/w) glucose solution within a 1 s integration interval, whereas the cubic ice formed in 50% (w/w) glucose solution did not transition to the hexagonal phase. The cubic phase was also confirmed in the 40% (w/w) ammonium hydrogen sulfate solution, but not in emulsified water. CONCLUSION The cubic-to-hexagonal ice phase transition was detected in three aqueous solutions tested upon freezing. It was not possible to clearly capture the transition process in emulsified water under the study condition.
Collapse
Affiliation(s)
- K Kondo
- Graduate School of Bionics, Computer and Media Science, Bionics Program, Tokyo University of Technology, Hachioji, Tokyo, Japan
| | - K Hara
- Graduate School of Engineering, Sustainable Engineering Program, Tokyo University of Technology, Hachioji, Tokyo, Japan
| | - O Keiichi
- Industrial Application Division, Japan Synchrotron Radiation Research Institute (JASRI), Mikazuki-cho, Sayou-gun, Hyogo, Japan
| | - S Abe
- Graduate School of Bionics, Computer and Media Science, Bionics Program, Tokyo University of Technology, Hachioji, Tokyo, Japan
| | - K Kajiwara
- Graduate School of Bionics, Computer and Media Science, Bionics Program, Tokyo University of Technology, Hachioji, Tokyo, Japan.
| |
Collapse
|
8
|
Akitsu TK, Nakaji T, Yoshida T, Sakai R, Mamiya W, Terigele, Takagi K, Honda Y, Kajiwara K, Nasahara KN. Field data for satellite validation and forest structure modeling in a pure and sparse forest of
Picea glehnii
in northern Hokkaido. Ecol Res 2020. [DOI: 10.1111/1440-1703.12114] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Tomoko K. Akitsu
- Faculty of Life and Environmental Sciences University of Tsukuba Tsukuba Japan
| | - Tatsuro Nakaji
- Uryu Experimental Forest, Field Science Center for Northern Biosphere Hokkaido University Horokanai Japan
| | - Toshiya Yoshida
- Nayoro Research Office, Field Science Center for Northern Biosphere Hokkaido University Nayoro Japan
| | - Rei Sakai
- Uryu Experimental Forest, Field Science Center for Northern Biosphere Hokkaido University Horokanai Japan
| | - Wataru Mamiya
- Uryu Experimental Forest, Field Science Center for Northern Biosphere Hokkaido University Horokanai Japan
| | - Terigele
- Graduate School of Life and Environmental Science University of Tsukuba Tsukuba Japan
| | - Kentaro Takagi
- Teshio Experimental Forest, Field Science Center for Northern Biosphere Hokkaido University Horonobe Japan
| | - Yoshiaki Honda
- Center for Environmental Remote Sensing Chiba University Chiba Japan
| | - Koji Kajiwara
- Center for Environmental Remote Sensing Chiba University Chiba Japan
| | - Kenlo N. Nasahara
- Faculty of Life and Environmental Sciences University of Tsukuba Tsukuba Japan
| |
Collapse
|
9
|
Takashima Y, Kawaguchi A, Iwadate Y, Hondoh H, Fukai J, Kajiwara K, Hayano A, Yamanaka R. miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma. PLoS One 2020; 15:e0229577. [PMID: 32101576 PMCID: PMC7043771 DOI: 10.1371/journal.pone.0229577] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2018] [Accepted: 02/11/2020] [Indexed: 12/13/2022] Open
Abstract
MicroRNAs (miRNAs) inhibit protein function by silencing the translation of target mRNAs. However, in primary central nervous system lymphoma (PCNSL), the expression and functions of miRNAs are inadequately known. Here, we examined the expression of 847 miRNAs in 40 PCNSL patients with a microarray and investigated for the miRNA predictors associated with cancer immunity-related genes such as T helper cell type 1/2 (Th-1/Th-2) and regulatory T cell (T-reg) status, and stimulatory and inhibitory checkpoint genes, for prognosis prediction in PCNSL. The aim of this study is to find promising prognosis markers based on the miRNA expression in PCNSL. We detected 334 miRNAs related to 66 cancer immunity-related genes in the microarray profiling. Variable importance measured by the random survival forest analysis and Cox proportional hazards regression model elucidated that 11 miRNAs successfully constitute the survival formulae dividing the Kaplan-Meier curve of the respective PCNSL subgroups. On the other hand, univariate analysis shortlisted 23 miRNAs for overall survival times, with four miRNAs clearly dividing the survival curves-miR-101/548b/554/1202. These miRNAs regulated Th-1/Th-2 status, T-reg cell status, and immune checkpoints. The miRNAs were also associated with gene ontology terms as Ras/MAP-kinase, ubiquitin ligase, PRC2 and acetylation, CDK, and phosphorylation, and several diseases including acquired immunodeficiency syndrome, glioma, and those related to blood and hippocampus with statistical significance. In conclusion, the results demonstrated that the four miRNAs comprising miR-101/548b/554/1202 associated with cancer immunity can be a useful prognostic marker in PCNSL and would help us understand target pathways for PCNSL treatments.
Collapse
Affiliation(s)
- Yasuo Takashima
- Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Atsushi Kawaguchi
- Center for Comprehensive Community Medicine, Faculty of Medicine, Saga University, Saga, Japan
| | - Yasuo Iwadate
- Department of Neurosurgery, Graduate School of Medical Sciences, Chiba University, Chiba, Japan
| | - Hiroaki Hondoh
- Departments of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan
| | - Junya Fukai
- Department of Neurological Surgery, Wakayama Medical University School of Medicine, Wakayama, Japan
| | - Koji Kajiwara
- Department of Neurosurgery, Graduate School of Medical Sciences, Yamaguchi University, Ube, Yamaguchi, Japan
| | - Azusa Hayano
- Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Ryuya Yamanaka
- Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
- * E-mail:
| |
Collapse
|
10
|
Kobayashi M, Kako J, Kajiwara K, Oosono Y, Noto H. Comment on: Predicting return to work among patients with colorectal cancer. Br J Surg 2020; 107:318. [DOI: 10.1002/bjs.11485] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Accepted: 11/28/2019] [Indexed: 01/24/2023]
Affiliation(s)
- M Kobayashi
- Faculty of Nursing, National Defense Medical College, Tokorozawa, Japan
| | - J Kako
- Division of Nursing Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
| | - K Kajiwara
- Division of Nursing Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
| | - Y Oosono
- Faculty of Nursing, National Defense Medical College, Tokorozawa, Japan
| | - H Noto
- Department of Health Sciences, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan
| |
Collapse
|
11
|
Takashima Y, Kawaguchi A, Iwadate Y, Hondoh H, Fukai J, Kajiwara K, Hayano A, Yamanaka R. MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma. PLoS One 2019; 14:e0210400. [PMID: 30615673 PMCID: PMC6322780 DOI: 10.1371/journal.pone.0210400] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2018] [Accepted: 12/15/2018] [Indexed: 02/06/2023] Open
Abstract
MicroRNAs (miRNAs) are small RNA molecules that inhibit gene function by suppressing translation of target genes. However, in primary central nervous system lymphoma (PCNSL), the biological significance of miRNAs is largely unknown, although some miRNAs are known to be prognosis markers. Here, we analyzed 847 miRNAs expressed in 27 PCNSL specimens using microarray profiling and surveyed miRNA signature for prognostic prediction. Of these, 16 miRNAs were expressed in 27 PCNSL specimens at a frequency of 48%. Their variable importance measured by Random forest model revealed miR-192, miR-486, miR-28, miR-52, miR-181b, miR-194, miR-197, miR-93, miR-708, and let-7g as having positive effects; miR-29b-2*, miR-126, and miR-182 as having negative effects; and miR-18a*, miR-425, and miR-30d as neutral. After principal component analysis, the prediction formula for prognosis, consisting of the expression values of the above-mentioned miRNAs, clearly divided Kaplan-Meier survival curves by the calculated Z-score (HR = 6.4566, P = 0.0067). The 16 miRNAs were enriched by gene ontology terms including angiogenesis, cell migration and proliferation, and apoptosis, in addition to signaling pathways including TGF-β/SMAD, Notch, TNF, and MAPKinase. Their target genes included BCL2-related genes, HMGA2 oncogene, and LIN28B cancer stem cell marker. Furthermore, three miRNAs including miR-181b, miR-30d, and miR-93, selected from the 16 miRNAs, also showed comparable results for survival (HR = 8.9342, P = 0.0007), suggestive of a miRNA signature for prognostic prediction in PCNSL. These results indicate that this miRNA signature is useful for prognostic prediction in PCNSL and would help us understand target pathways for therapies in PCNSL.
Collapse
Affiliation(s)
- Yasuo Takashima
- Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Atsushi Kawaguchi
- Center for Comprehensive Community Medicine, Faculty of Medicine, Saga University, Saga, Japan
| | - Yasuo Iwadate
- Department of Neurosurgery, Graduate School of Medical Sciences, Chiba University, Chiba, Japan
| | - Hiroaki Hondoh
- Departments of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan
| | - Junya Fukai
- Department of Neurological Surgery, Wakayama Medical University School of Medicine, Wakayama, Japan
| | - Koji Kajiwara
- Department of Neurosurgery, Graduate School of Medical Sciences, Yamaguchi University, Ube, Yamaguchi, Japan
| | - Azusa Hayano
- Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Ryuya Yamanaka
- Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
- * E-mail:
| |
Collapse
|
12
|
Nagai S, Akitsu T, Saitoh TM, Busey RC, Fukuzawa K, Honda Y, Ichie T, Ide R, Ikawa H, Iwasaki A, Iwao K, Kajiwara K, Kang S, Kim Y, Khoon KL, Kononov AV, Kosugi Y, Maeda T, Mamiya W, Matsuoka M, Maximov TC, Menzel A, Miura T, Mizunuma T, Morozumi T, Motohka T, Muraoka H, Nagano H, Nakai T, Nakaji T, Oguma H, Ohta T, Ono K, Pungga RAS, Petrov RE, Sakai R, Schunk C, Sekikawa S, Shakhmatov R, Son Y, Sugimoto A, Suzuki R, Takagi K, Takanashi S, Tei S, Tsuchida S, Yamamoto H, Yamasaki E, Yamashita M, Yoon TK, Yoshida T, Yoshimura M, Yoshitake S, Wilkinson M, Wingate L, Nasahara KN. 8 million phenological and sky images from 29 ecosystems from the Arctic to the tropics: the Phenological Eyes Network. Ecol Res 2018. [DOI: 10.1007/s11284-018-1633-x] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
13
|
Takashima Y, Sasaki Y, Hayano A, Homma J, Fukai J, Iwadate Y, Kajiwara K, Ishizawa S, Hondoh H, Tokino T, Yamanaka R. Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma. Oncotarget 2018; 9:27471-27486. [PMID: 29937999 PMCID: PMC6007945 DOI: 10.18632/oncotarget.25463] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2018] [Accepted: 05/02/2018] [Indexed: 01/02/2023] Open
Abstract
Exome-sequencing for somatic mutation detection and copy number variation analysis are effective and valid methods for evaluating human cancers in current molecular medicine. We conducted target amplicon exome-sequencing analyses using PCR target enrichment and next-generation sequencing on Ion Proton semiconductor sequencers. Twenty-seven primary central nervous system lymphoma (PCNSL) specimens and their corresponding noncancerous tissues were used for multiplex PCR amplification to obtain targeted coverages of the entire coding regions of 409 cancer-related genes. The average of the total numbers of somatic mutations including single-nucleotide variations and insertion/deletion mutations in each specimen was 13.3. Of these, the average of the ratios of nonsynonymous substitutions in each specimen was 74.8%. The most frequent mutations in 27 specimens were in PIM1, MYD88, CD79B, DST, IRF4, ERBB3, MYH11, DCC, and KMT2D. Furthermore, somatic mutations of MYH11 were related to poor prognoses in PCNSL patients. Copy number variations were also duplicated and/or deleted from deep-sequencing in segmental genomic islands. In addition to these prognostic marker candidates, analysis of RTK-RAS-MAPK signaling and the PTEN-PI3K-AKT proapoptotic pathway showed that somatic activations and aberrations, respectively, may be involved in a promising central oncopathway harboring mTOR, c-Myc, FOXO1, and p53. This study provides a foundation for molecular targeted therapies based on genome diagnostics and prognosis in PCNSL.
Collapse
Affiliation(s)
- Yasuo Takashima
- Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Yasushi Sasaki
- Center for Medical Education, Sapporo Medical University, Sapporo, Japan
| | - Azusa Hayano
- Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Jumpei Homma
- Department of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan
| | - Junya Fukai
- Department of Neurological Surgery, Wakayama Medical University School of Medicine, Wakayama, Japan
| | - Yasuo Iwadate
- Department of Neurosurgery, Graduate School of Medical Sciences, Chiba University, Chiba, Japan
| | - Koji Kajiwara
- Department of Neurosurgery, Graduate School of Medical Sciences, Yamaguchi University, Ube, Yamaguchi, Japan
| | - Shin Ishizawa
- Department of Pathology, Toyama Prefectural Central Hospital, Toyama, Japan
| | - Hiroaki Hondoh
- Department of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan
| | - Takashi Tokino
- Research Institute for Frontier Medicine, Sapporo Medical University, Sapporo, Japan
| | - Ryuya Yamanaka
- Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| |
Collapse
|
14
|
Hayano A, Komohara Y, Takashima Y, Takeya H, Homma J, Fukai J, Iwadate Y, Kajiwara K, Ishizawa S, Hondoh H, Yamanaka R. Programmed Cell Death Ligand 1 Expression in Primary Central Nervous System Lymphomas: A Clinicopathological Study. Anticancer Res 2017; 37:5655-5666. [PMID: 28982883 DOI: 10.21873/anticanres.12001] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2017] [Revised: 09/19/2017] [Accepted: 09/20/2017] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM Programmed cell death ligand 1 (PD-L1)/programmed cell death 1 (PD-1) have been shown to predict response to PD-L1/PD-1-targeted therapy. We analyzed PD-L1 expression in primary central nervous system lymphomas (PCNSLs). MATERIALS AND METHODS PD-L1 protein and mRNA expression were evaluated in 64 PCNSL tissue samples. IFN-γ, IL-10, CD4, and CD8 mRNA expression was also evaluated. RESULTS PD-L1 protein was detected in tumor cells in 2 (4.1%) cases and in tumor microenvironments in 25 (52%) cases. PD-L1 mRNA positively correlated with IFN-γ (p=0.0024) and CD4 (p=0.0005) mRNA expression. IFN-γ mRNA positively correlated with CD8 mRNA expression (p=0.0001). Furthermore, tumor cell PD-L1 expression correlated positively with overall survival (p=0.0177), whereas microenvironmental PD-L1 expression exhibited an insignificant negative trend with overall survival (p=0.188). CONCLUSION PD-L1 was expressed on both tumor and/or tumor-infiltrating immune cells in PCNSL. The biological roles of this marker warrant further investigation.
Collapse
Affiliation(s)
- Azusa Hayano
- Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Yoshihiro Komohara
- Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
| | - Yasuo Takashima
- Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Hiroto Takeya
- Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
| | - Jumpei Homma
- Department of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan
| | - Junya Fukai
- Department of Neurological Surgery, Wakayama Medical University School of Medicine, Wakayama, Japan
| | - Yasuo Iwadate
- Department of Neurosurgery, Graduate School of Medical Sciences, Chiba University, Chiba, Japan
| | - Koji Kajiwara
- Department of Neurosurgery, Graduate School of Medical Sciences, Yamaguchi University, Ube, Japan
| | - Shin Ishizawa
- Department of Pathology, Toyama Prefectural Central Hospital, Toyama, Japan
| | - Hiroaki Hondoh
- Department of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan
| | - Ryuya Yamanaka
- Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| |
Collapse
|
15
|
Kajiwara K, Oda Y, Takahashi K, Kasugai A, Sakamoto K. Design and Operation of TE31,12 High Power Gyrotron. Fusion Science and Technology 2017. [DOI: 10.13182/fst13-a16870] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- K. Kajiwara
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - Y. Oda
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - K. Takahashi
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - A. Kasugai
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - K. Sakamoto
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| |
Collapse
|
16
|
Kobayashi T, Isayama A, Sawahata M, Suzuki S, Terakado M, Hiranai S, Wada K, Sato Y, Hinata J, Yokokura K, Hoshino K, Kajiwara K, Sakamoto K, Moriyama S. Dual Frequency ECRF System Development for JT-60SA. Fusion Science and Technology 2017. [DOI: 10.13182/fst13-a16895] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- T. Kobayashi
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - A. Isayama
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - M. Sawahata
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - S. Suzuki
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - M. Terakado
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - S. Hiranai
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - K. Wada
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - Y. Sato
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - J. Hinata
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - K. Yokokura
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - K. Hoshino
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - K. Kajiwara
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - K. Sakamoto
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| | - S. Moriyama
- Japan Atomic Energy Agency: Mukoyama 801-1, Naka, Ibaraki, 311-0193 Japan
| |
Collapse
|
17
|
Oda Y, Ikeda R, Takahashi K, Kajiwara K, Kobayashi T, Sakamoto K, Moriyama S, Darbos C, Henderson M. Recent activities of ITER gyrotron development in QST. EPJ Web Conf 2017. [DOI: 10.1051/epjconf/201714901002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
18
|
Lohr J, Gorelov YA, Kajiwara K, Ponce D, Callis RW, Doane JL, Ellis RL, Grunloh HJ, Moeller CP, Peavey J, Prater R, Tooker JF. The Electron Cyclotron Resonant Heating System on the DIII-D Tokamak. Fusion Science and Technology 2017. [DOI: 10.13182/fst05-a1073] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- John Lohr
- General Atomics, DIII-D National Fusion Facility, San Diego, California
| | - Y. A. Gorelov
- General Atomics, DIII-D National Fusion Facility, San Diego, California
| | - K. Kajiwara
- General Atomics, DIII-D National Fusion Facility, San Diego, California
| | - Dan Ponce
- General Atomics, DIII-D National Fusion Facility, San Diego, California
| | - R. W. Callis
- General Atomics, DIII-D National Fusion Facility, San Diego, California
| | - J. L. Doane
- General Atomics, DIII-D National Fusion Facility, San Diego, California
| | - R. L. Ellis
- General Atomics, DIII-D National Fusion Facility, San Diego, California
| | - H. J. Grunloh
- General Atomics, DIII-D National Fusion Facility, San Diego, California
| | - C. P. Moeller
- General Atomics, DIII-D National Fusion Facility, San Diego, California
| | - J. Peavey
- General Atomics, DIII-D National Fusion Facility, San Diego, California
| | - R. Prater
- General Atomics, DIII-D National Fusion Facility, San Diego, California
| | - J. F. Tooker
- General Atomics, DIII-D National Fusion Facility, San Diego, California
| |
Collapse
|
19
|
Gandini F, Bigelow TS, Becket B, Caughman JB, Cox D, Darbos C, Gassmann T, Henderson MA, Jean O, Kajiwara K, Kobayashi N, Nazare C, Oda Y, Omori T, Purohit D, Rasmussen DA, Ronden DMS, Saibene G, Sakamoto K, Shapiro MA, Takahashi K, Temkin RJ. The EC H&CD Transmission Line for ITER. Fusion Science and Technology 2017. [DOI: 10.13182/fst05-38] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- F. Gandini
- ITER Organization, CS 90 046 - 13067 Saint Paul Lez Durance Cedex, France
| | - T. S. Bigelow
- U.S. ITER Project Office, ORNL, 1055 Commerce Park, Oak Ridge, Tennessee 37831
| | - B. Becket
- ITER Organization, CS 90 046 - 13067 Saint Paul Lez Durance Cedex, France
| | - J. B. Caughman
- U.S. ITER Project Office, ORNL, 1055 Commerce Park, Oak Ridge, Tennessee 37831
| | - D. Cox
- ITER Organization, CS 90 046 - 13067 Saint Paul Lez Durance Cedex, France
| | - C. Darbos
- ITER Organization, CS 90 046 - 13067 Saint Paul Lez Durance Cedex, France
| | - T. Gassmann
- ITER Organization, CS 90 046 - 13067 Saint Paul Lez Durance Cedex, France
| | - M. A. Henderson
- ITER Organization, CS 90 046 - 13067 Saint Paul Lez Durance Cedex, France
| | - O. Jean
- ITER Organization, CS 90 046 - 13067 Saint Paul Lez Durance Cedex, France
| | - K. Kajiwara
- Japan Atomic Energy Agency, 801-1 Mukoyama, Naka-shi, Ibaraki 311-0193, Japan
| | - N. Kobayashi
- Japan Atomic Energy Agency, 801-1 Mukoyama, Naka-shi, Ibaraki 311-0193, Japan
| | - C. Nazare
- Assystem Facilities, 23 Place de Wicklow CS 30713, 78067 Saint Quentin en Yvelines Cedex, France
| | - Y. Oda
- Japan Atomic Energy Agency, 801-1 Mukoyama, Naka-shi, Ibaraki 311-0193, Japan
| | - T. Omori
- ITER Organization, CS 90 046 - 13067 Saint Paul Lez Durance Cedex, France
| | - D. Purohit
- ITER Organization, CS 90 046 - 13067 Saint Paul Lez Durance Cedex, France
| | - D. A. Rasmussen
- U.S. ITER Project Office, ORNL, 1055 Commerce Park, Oak Ridge, Tennessee 37831
| | - D. M. S. Ronden
- Association EURATOM-FOM, 3430 BE Nieuwegein, The Netherlands
| | - G. Saibene
- Fusion for Energy, C/Josep Pla 2, Torres Diagonal Litoral-B3, E-08019 Barcelona, Spain
| | - K. Sakamoto
- Japan Atomic Energy Agency, 801-1 Mukoyama, Naka-shi, Ibaraki 311-0193, Japan
| | - M. A. Shapiro
- MIT Plasma Science and Fusion Center, Cambridge, Massachusetts 02139
| | - K. Takahashi
- Japan Atomic Energy Agency, 801-1 Mukoyama, Naka-shi, Ibaraki 311-0193, Japan
| | - R. J. Temkin
- MIT Plasma Science and Fusion Center, Cambridge, Massachusetts 02139
| |
Collapse
|
20
|
Ikeda Y, Kasugai A, Moriyama S, Kajiwara K, Seki M, Tsuneoka M, Takahashi K, Anno K, Hamamatsu K, Hiranai S, Ikeda Y, Imai T, Sakamoto K, Shimono M, Shinozaki S, Terakado M, Yamamoto T, Yokokura K, Fujii T. The 110-GHz Electron Cyclotron Range of Frequency System on JT-60U: Design and Operation. Fusion Science and Technology 2017. [DOI: 10.13182/fst02-a239] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Y. Ikeda
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - A. Kasugai
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - S. Moriyama
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - K. Kajiwara
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - M. Seki
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - M. Tsuneoka
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - K. Takahashi
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - K. Anno
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - K. Hamamatsu
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - S. Hiranai
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - Yu. Ikeda
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - T. Imai
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - K. Sakamoto
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - M. Shimono
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - S. Shinozaki
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - M. Terakado
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - T. Yamamoto
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - K. Yokokura
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| | - T. Fujii
- Japan Atomic Energy Research Institute Naka Fusion Research Establishment, Naka-machi, Ibaraki-ken 311-0193, Japan
| |
Collapse
|
21
|
Yang HL, Kwak JG, Oh YK, Park KR, Kim WC, Lee SG, Kim JY, Bae YS, Park YM, Kim HK, Chu Y, Park MK, Kim JS, In SR, Joung SH, Choe WH, Park HK, Hwang YS, Na YS, Park JG, Ahn JW, Park YS, Kwon M, Leuer JA, Eidietis NW, Hyatt AW, Walker M, Gorelov Y, Lohr J, Mueller D, Grisham LR, Sabbagh SA, Watanabe K, Inoue T, Sakamoto K, Oda Y, Kajiwara K, Ellis R, Hosea J, Delpech L, Hoang TT, Litaudon X, Namkung W, Cho MH. Overview of KSTAR Results in Phase-I Operation. Fusion Science and Technology 2017. [DOI: 10.13182/fst13-a19130] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- H. L. Yang
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - J. G. Kwak
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - Y. K. Oh
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - K. R. Park
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - W. C. Kim
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - S. G. Lee
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - J. Y. Kim
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - Y. S. Bae
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - Y. M. Park
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - H. K. Kim
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - Y. Chu
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - M. K. Park
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - J. S. Kim
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - S. R. In
- Korea Atomic Energy Research Insititute, Daeduk-Daero 989-111, Yuseong-gu, Daejeon, 305-353, Korea
| | - S. H. Joung
- Korea Atomic Energy Research Insititute, Daeduk-Daero 989-111, Yuseong-gu, Daejeon, 305-353, Korea
| | - W. H. Choe
- Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon, 305-701, Korea
| | - H. K. Park
- Pohang Univ. of Science and Technology, 77 Cheongam-ro, Nam-gu, Pohang, Gyungbuk, 790-784, Korea
| | - Y. S. Hwang
- Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 151-742, Korea
| | - Y. S. Na
- Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 151-742, Korea
| | - J. G. Park
- Princeton Plasma Physics Lab., P.O. Box 451 Princetorn, NJ 08543-0451, USA
| | - J. W. Ahn
- Oak Ridge National Lab., 1 Bethal Valley Rd, OakRidge, TN37831, USA
| | - Y. S. Park
- Columbia Univ., James Forrestal Campus (EWA 244), P.O. Box 451, Princeton, NJ 08543, USA
| | - M. Kwon
- National Fusion Research Institute, 113 Gwahangno, Yusung-Gu, Daejeon, 305-333, Korea
| | - J. A. Leuer
- General Atomics, 3550 General Atomics Court, San Diego, CA 92121, USA
| | - N. W. Eidietis
- General Atomics, 3550 General Atomics Court, San Diego, CA 92121, USA
| | - A. W. Hyatt
- General Atomics, 3550 General Atomics Court, San Diego, CA 92121, USA
| | - M. Walker
- General Atomics, 3550 General Atomics Court, San Diego, CA 92121, USA
| | - Y. Gorelov
- General Atomics, 3550 General Atomics Court, San Diego, CA 92121, USA
| | - J. Lohr
- General Atomics, 3550 General Atomics Court, San Diego, CA 92121, USA
| | - D. Mueller
- Princeton Plasma Physics Lab., P.O. Box 451 Princetorn, NJ 08543-0451, USA
| | - L. R. Grisham
- Princeton Plasma Physics Lab., P.O. Box 451 Princetorn, NJ 08543-0451, USA
| | - S. A. Sabbagh
- Columbia Univ., James Forrestal Campus (EWA 244), P.O. Box 451, Princeton, NJ 08543, USA
| | - K. Watanabe
- Japan Atomic Energy Agency, 801-1 Mukoyama, Naka-city, Ibaraki-ken, 311-0193, Japan
| | - T. Inoue
- Japan Atomic Energy Agency, 801-1 Mukoyama, Naka-city, Ibaraki-ken, 311-0193, Japan
| | - K. Sakamoto
- Japan Atomic Energy Agency, 801-1 Mukoyama, Naka-city, Ibaraki-ken, 311-0193, Japan
| | - Y. Oda
- Japan Atomic Energy Agency, 801-1 Mukoyama, Naka-city, Ibaraki-ken, 311-0193, Japan
| | - K. Kajiwara
- Japan Atomic Energy Agency, 801-1 Mukoyama, Naka-city, Ibaraki-ken, 311-0193, Japan
| | - R. Ellis
- Princeton Plasma Physics Lab., P.O. Box 451 Princetorn, NJ 08543-0451, USA
| | - J. Hosea
- Princeton Plasma Physics Lab., P.O. Box 451 Princetorn, NJ 08543-0451, USA
| | - L. Delpech
- CEA, IFRM,13108 Saint-Paul-Lez-Durance, France
| | - T. T. Hoang
- CEA, IFRM,13108 Saint-Paul-Lez-Durance, France
| | - X. Litaudon
- CEA, IFRM,13108 Saint-Paul-Lez-Durance, France
| | - W. Namkung
- Pohang Univ. of Science and Technology, 77 Cheongam-ro, Nam-gu, Pohang, Gyungbuk, 790-784, Korea
| | - M. H. Cho
- Pohang Univ. of Science and Technology, 77 Cheongam-ro, Nam-gu, Pohang, Gyungbuk, 790-784, Korea
| | | |
Collapse
|
22
|
Takahashi K, Kajiwara K, Oda Y, Sakamoto K, Omori T, Henderson M. Development of ITER Equatorial EC Launcher Components Toward the Final Design. Fusion Science and Technology 2017. [DOI: 10.13182/fst14-830] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- K. Takahashi
- Japan Atomic Energy Agency, 801-1, Mukoyama, Naka, Ibaraki 311-0193 Japan
| | - K. Kajiwara
- Japan Atomic Energy Agency, 801-1, Mukoyama, Naka, Ibaraki 311-0193 Japan
| | - Y. Oda
- Japan Atomic Energy Agency, 801-1, Mukoyama, Naka, Ibaraki 311-0193 Japan
| | - K. Sakamoto
- Japan Atomic Energy Agency, 801-1, Mukoyama, Naka, Ibaraki 311-0193 Japan
| | - T. Omori
- Japan Atomic Energy Agency, 801-1, Mukoyama, Naka, Ibaraki 311-0193 Japan
| | - M. Henderson
- ITER Organization, Route de Vinon sur Verdon, CS 90 046, 13067 St. Paul Lez Durance Cedex, France
| |
Collapse
|
23
|
Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Bartels DB, Lip GY, Abban D, Abdul N, Abelson M, Ackermann A, Adams F, Adams L, Adragão P, Ageno W, Aggarwal R, Agosti S, Marin JA, Aguilar F, Aguilar Linares JA, Aguinaga L, Ahmad Z, Ainsworth P, Al Ghalayini K, Al Ismail S, Alasfar A, Alawwa A, Al-Dallow R, Alderson L, Alexopoulos D, Ali A, Ali M, Aliyar P, Al-Joundi T, Al Mahameed S, Almassi H, Almuti K, Al-Obaidi M, Alshehri M, Altmann U, Alves AR, Al-Zoebi A, Amara W, Amelot M, Amjadi N, Ammirati F, Andrawis N, Angoulvant D, Annoni G, Ansalone G, Antonescu SA, Ariani M, Arias JC, Armero S, Arora R, Arora C, Ashcraft W, Aslam MS, Astesiano A, Audouin P, Augenbraun C, Aydin S, Azar R, Azim A, Aziz S, Backes LM, Baig M, Bains S, Bakbak A, Baker S, Bakhtiar K, Bala R, Banayan J, Bandh S, Bando S, Banerjee S, Bank A, Barbarash O, Barón G, Barr C, Barrera C, Barton J, Kes VB, Baula G, Bayeh H, Bazargani N, Behrens S, Bell A, Benezet-Mazuecos J, Benhalima B, Berdagué P, Berg van den B, Bergen van P, Berngard E, Bernstein R, Yao J, Yarlagadda C, Yeh KH, Yotov Y, Yvorra S, Zahn R, Zamorano J, Zanini R, Zarich S, Zebrack J, Berrospi P, Zenin S, Zeuthen EL, Zhang X, Zhang Q, Zhang D, Zhang D, Zhang H, Zhao S, Zhao X, Zheng Y, Berti S, Zheng Q, Zhou J, Zhou J, Zimmermann SL, Zimmermann R, Zukerman LS, Zwaan van der C, Bertomeu V, Berz A, Bettencourt P, Betzu R, Beyer-Westendorf J, Bhagwat R, Black T, Blanco Ibaceta JH, Bloom S, Blumberg E, Bo M, Bockisch V, Bøhmer E, Bongiorni MG, Boriani G, Bosch R, Boswijk D, Bott J, Bottacchi E, Kalan MB, Brandes A, Bratland B, Brautigam D, Breton N, Brouwers P, Browne K, Bruguera J, Brunehaut M, Brunschwig C, Buathier H, Buhl A, Bullinga J, Butcher K, Cabrera Honorio JW, Caccavo A, Cadinot D, Cai S, Calvi V, Camm J, Candeias R, Capo J, Capucci A, Cardoso JN, Duarte Vera YC, Carlson B, Carvalho P, Cary S, Casanova R, Casu G, Cattan S, Cavallini C, Cayla G, Cha TJ, Cha KS, Chaaban S, Chae JK, Challappa K, Chand S, Chandrashekar H, Chang M, Charbel P, Chartier L, Chatterjee K, Cheema A, Chen SA, Chevallereau P, Chiang FT, Chiarella F, Chih-Chan L, Cho YK, Choi DJ, Chouinard G, Danny, Chow HF, Chrysos D, Chumakova G, José Roberto Chuquiure Valenzuela EJ, Cieza-Lara T, Nica VC, Ciobotaru V, Cislowski D, Citerne O, Claus M, Clay A, Clifford P, Cohen S, Cohen A, Colivicchi F, Collins R, Compton S, Connors S, Conti A, Buenostro GC, Coodley G, Cooper M, Corbett L, Corey O, Coronel J, Corrigan J, Cotrina Pereyra RY, Cottin Y, Coutu B, Cracan A, Crean P, Crenshaw J, Crijns H, Crump C, Cucher F, Cudmore D, Cui L, Culp J, Darius H, Dary P, Dascotte O, Dauber I, Davee T, Davies R, Davis G, Davy JM, Dayer M, De La Briolle A, de Mora M, De Teresa E, De Wolf L, Decoulx E, Deepak S, Defaye P, Del-Carpio Munoz F, Brkljacic DD, Deluche L, Destrac S, Deumite N, Di Legge S, Dibon O, Diemberger I, Dillinger J, Dionísio P, Naydenov S, Dotani I, Dotcheva E, D'Souza A, Dubrey S, Ducrocq X, Dupljakov D, DuThinh V, Dutra OP, Dutta D, Duvilla N, Dy J, Dziewas R, Eaton C, Eaves W, Ebinger M, Eck van J, Edwards T, Egocheaga I, Ehrlich C, Eisenberg S, El Hallak A, El Jabali A, El Mahmoud R, El Shahawy M, Eldadah Z, Elghelbazouri F, Elhag O, El-Hamdani M, Elias D, Ellery A, El-Sayed H, Elvan A, Erickson B, Espaliat E, Essandoh L, Everington T, Evonich R, Ezhov A, Fácila L, Farsad R, Fayard M, Fedele F, Gomes Ferreira LG, Ferreira D, Santos JF, Ferrier A, Finsen A, First B, Fisher R, Floyd J, Folk T, Fonseca C, Fonseca L, Forman S, Forsgren M, Foster M, Foster N, Frais M, Frandsen B, Frappé T, Freixa R, French W, Freydlin M, Frickel S, Fruntelata AG, Fujii S, Fujino Y, Fukunaga H, Furukawa Y, Gabelmann M, Gabris M, Gadsbøll N, Galin P, Galinier M, Ganim R, Garcia R, Quintana AG, Gartenlaub O, Genz C, Georger F, Georges JL, Georgeson S, Ghanbasha A, Giedrimas E, Gierba M, Gillespie E, Giniger A, Gkotsis A, Gmehling J, Gniot J, Goethals P, Goldberg R, Goldmann B, Goldscher D, Golitsyn S, Gomez Lopez EA, Gomez Mesa JE, Gonzalez E, Cocina EG, Juanatey CG, Gorbunov V, Gordon B, Gorka H, Gornick C, Gorog D, Goss F, Götte A, Goube P, Goudevenos I, Goulden D, Graham B, Grande A, Greco C, Green M, Greer G, Gremmler U, Grena P, Grinshstein Y, Grond M, Gronda E, Grondin F, Grönefeld G, Groot de J, Guardigli G, Guarnieri T, Caiedo CG, Guignier A, Gulizia M, Gumbley M, Gupta D, Hack T, Haerer W, Hakas J, Hall C, Hampsey J, Hananis G, Hanbali B, Handel F, Hargrove J, Hargroves D, Harris K, Hartley D, Haruna T, Hata Y, Hayek E, Healey J, Hearne S, Heggelund G, Hemels M, Hemery Y, Henein S, Henz B, Her SH, Hermany P, Hernandes ME, Higashino Y, Hill M, Hisadome T, Hishida E, Hitchcock J, Hoffer E, Hoghton M, Holmes C, Hong SK, Houppe Nousse MP, Howard V, Hsu LF, Huang CH, Huckins D, Huehnergarth K, Huizenga A, Huntley R, Hussein G, Hwang GS, Igbokidi O, Iglesias I, Ikpoh M, Imberti D, Ince H, Indolfi C, Ionova T, Ip J, Irles D, Iseki H, Ismail Y, Israel N, Isserman S, Iteld B, Ivanchura G, Iyer R, Iyer V, Iza Villanueva RO, Jackson-Voyzey E, Jaffrani N, Jäger F, Jain M, James M, Jamon Y, Jang SW, Pereira Jardim CA, Jarmukli N, Jeanfreau R, Jenkins R, Jiang X, Jiang H, Jiang T, Jiang N, Jimenez J, Jobe R, Joffe I, Johansson B, Jones N, Moura Jorge JC, Jouve B, Jundi M, Jung W, Jung BC, Jung KT, Kabbani S, Kabour A, Kafkala C, Kajiwara K, Kalinina L, Kampus P, Kanda J, Kapadia S, Karim A, Karolyi L, Kashou H, Kastrup A, Katsivas A, Kaufman E, Kawai K, Kawajiri K, Kazmierski J, Keeling P, Kerfes GA, Kerr Saraiva JF, Ketova G, Khaira A, Khalid M, Khludeeva E, Khripun A, Kim DI, Kim DK, Kim NH, Kim KS, Kim YH, Kim JB, Kim JS, Kim JS, Kinova E, Klein A, Kleinschnitz C, Kmetzo J, Kneller GL, Knezevic A, Koch S, Koenig K, Angela Koh SM, Köhrmann M, Koons J, Korabathina R, Korennova O, Koschutnik M, Kosinski E, Kovacic D, Kowalczyk J, Koziolova N, Kragten J, Krause LU, Kreidieh I, Krenning B, Krishnaswamy K, Krysiak W, Kuck KH, Kumar S, Kümler T, Kuniss M, Kuo JY, Küppers A, Kurrelmeyer K, Kwan T, Kyo E, Labovitz A, Lacroix A, Lam A, Lanas Zanetti FT, Landau C, Landini G, Lang W, Larsen TB, Laske V, Lavandier K, Law N, Lee MH, Lee D, Leitão A, Lejay D, Lelonek M, Lenarczyk R, Leprince P, Lequeux B, Leschke M, Ley N, Li Z, Li Y, Li X, Li Z, Li W, Liang J, Lieber I, Lillestol M, Limon Rodriguez RH, Lin H, Lip G, Litchfield J, Liu Z, Liu X, Liu Y, Liu F, Liu W, Llamas Esperon GA, Llisterri JL, Lo T, Lo E, Lobos JM, Lodde BP, Loiselet P, López-Sendón J, Lorga Filho AM, Lori I, Luo M, Lupovitch S, Lyrer P, Zuhairy HM, Ma C, Ma G, Ma H, Madariaga I, Maeno K, Magnin D, Mahmood S, Mahood K, Maid G, Mainigi S, Makaritsis K, Maldonado Villalon JA, Malhotra R, Malik A, Mallecourt C, Mallik R, Manning R, Manolis A, Mantas I, Manzur Jattin FG, Marcionni N, Marín F, Santana AM, Martinez J, Martinez L, Maskova P, Hernández NM, Matskeplishvili S, Matsuda K, Mavri A, May E, Mayer N, Mazon P, McClure J, McCormack T, McGarity W, McGuire M, McIntyre H, McLaughlin P, McLaurin B, Medina Palomino FA, Mehta P, Mehzad R, Meinel A, Melandri F, Mena A, Meno H, Menzies D, Metcalf K, Meyer B, Miarka J, Mibach F, Michalski D, Michel P, Chreih RM, Mikdadi G, Mikhail M, Mikus M, Milicic D, Militaru C, Miller G, Milonas C, Minescu B, Mintale I, Miralles A, Mirault T, Mistry D, Mitchell G, Miu NV, Miyamoto N, Moccetti T, Mohammed A, Nor AM, Molina de Salazar DI, Molon G, Molony D, Mondillo S, Mont L, Moodley R, Moore R, Ribeiro Moreira DA, Mori K, Moriarty A, Morka J, Moschos N, Mota Gomes MA, Mousallem N, Moya A, Mügge A, Mulhearn T, Muller JJ, Muresan CM, Muse D, Musial W, Musumeci F, Nadar V, Nageh T, Nair P, Nakagawa H, Nakamura Y, Nakayama T, Nam KB, Napalkov D, Natarajan I, Nayak H, Nechvatal L, Neiman J, Nerheim P, Neuenschwander FC, Nishida K, Nizov A, Novikova T, Novo S, Nowalany-Kozielska E, Nsah E, Nunez Fragoso JC, Nyvad O, de Los Rios Ibarra MO, O'Donnell M, O'Donnell P, Oh DJ, Oh YS, Daniel Oh CT, O'Hara G, Oikonomou K, Olalla JJ, Olivari Z, Oliver R, Olympios C, Osborne J, Osca J, Osman R, Osunkoya A, Padanilam B, Panchenko E, Pandey AS, Vicenzo de Paola AA, Paraschos A, Pardell H, Park HW, Park JS, Parkash R, Parker I, Parrens E, Parris R, Passamonti E, Patel J, Patel R, Pentz WH, Persic V, Perticone F, Peters P, Petkar S, Pezo LF, Pham D, Cao Phai GP, Phlaum S, Pineau J, Pineda-Velez A, Pini R, Pinter A, Pinto F, Pirelli S, Pivac N, Pizzini AM, Pocanic D, Calin Podoleanu CG, Polanczyk CA, Polasek P, Poljakovic Z, Pollock S, Polo J, Poock J, Poppert H, Porro Y, Pose A, Poulain F, Poulard JE, Pouzar J, Povolny P, Pozzer D, Pras A, Prasad N, Prevot S, Protasov K, Prunier L, Puleo J, Pye M, Qaddoura F, Quedillac JM, Raev D, Rahimi S, Raisaro A, Rama B, Ranadive N, Randall K, Ranjith N, Raposo N, Rashid H, Raters C, Rauch-Kroehnert U, Rebane T, Regner S, Renzi M, Reyes Rocha MA, Reza S, Ria L, Richter D, Rickli H, Rickner K, Rieker W, Rigo F, Ripoll T, Fonteles Ritt LE, Roberts D, Pascual CR, Briones IR, Reyes HR, Roelke M, Roman M, Romeo F, Ronner E, Ronziere T, Rooyer F, Rosenbaum D, Roth S, Rozkova N, Rubacek M, Rubalcava F, Rubanenko O, Rubin A, Borret MR, Rybak K, Sabbour H, Morales OS, Sakai T, Salacata A, Salecker I, Salem A, Salfity M, Salguero R, Salvioni A, Samson M, Sanchez G, Sandesara C, Saporito WF, Sasaoka T, Sattar P, Savard D, Scala PJ, Scemama J, Schaupp T, Schellinger P, Scherr C, Schmitz KH, Schmitz B, Schmitz L, Schnitzler R, Schnupp S, Schoeniger P, Schön N, Schuster S, Schwimmbeck P, Seamark C, Seebass R, Seidl KH, Seidman B, Sek J, Sekaran L, Seko Y, Sepulveda Varela PA, Sevilla B, Shah V, Shah A, Shah N, Shah A, Shanes J, Sharareh A, Sharma VK, Shaw L, Shimizu Y, Shimomura H, Shin DG, Shin ES, Shite J, Shoukfeh M, Shoultz C, Silver F, Sime I, Simmers T, Singal D, Singh N, Siostrzonek P, Sirajuddin M, Skeppholm M, Smadja D, Smith R, Smith D, Soda H, Sofley CW, Sokal A, Sotolongo R, de Souza OF, Sparby JA, Spinar J, Sprigings D, Spyropoulos A, Stakos D, Steinberg A, Steinwender C, Stergiou G, Stites HW, Stoikov A, Strasser R, Streb W, Styliadis I, Su G, Su X, Suarez RM, Sudnik W, Sueyoshi A, Sukles K, Sun L, Suneja R, Svensson P, Ziekenhuis A, Szavits-Nossan J, Taggeselle J, Takagi Y, Takhar A, Tallet J, Tamm A, Tanaka S, Tanaka K, Tang A, Tang S, Tassinari T, Tayama S, Tayebjee M, Tebbe U, Teixeira J, Tesloianu DN, Tessier P, The S, Thevenin J, Thomas H, Timsit S, Topkis R, Torosoff M, Touze E, Traissac T, Trendafilova E, Troyan B, Tsai WK, Tse HF, Tsutsui H, Tsutsui T, Tuininga Y, Turakhia M, Turk S, Turner W, Tveit A, Twiddy S, Tytus R, Ukrainski G, Valdovinos Chavez SB, Van De Graaff E, Vanacker P, Vardas P, Vargas M, Vassilikos V, Vazquez J, Venkataraman A, Verdecchia P, Vester EG, Vial H, Vinereanu D, Vlastaris A, Vogel C, vom Dahl J, von Mering M, Vora K, Wakefield P, Walia J, Walter T, Wang M, Wang N, Wang F, Wang X, Wang Z, Wang KY, Watanabe K, Wei J, Weimar C, Weinrich R, Wen MS, Wheelan K, Wicke J, Wiemer M, Wild B, Wilke A, Willems S, Williams M, Williams D, Winkler A, Wirtz JH, Witzenbichler B, Wong DH, Lawrence Wong KS, Wong B, Wozakowska-Kaplon B, Wu Z, Wu S, Wyatt N, Xu Y, Xu X, Yamada A, Yamamoto K, Yamanoue H, Yamashita T, Bryan Yan PY, Yang Y, Yang T. The Changing Landscape for Stroke Prevention in AF. J Am Coll Cardiol 2017; 69:777-785. [DOI: 10.1016/j.jacc.2016.11.061] [Citation(s) in RCA: 215] [Impact Index Per Article: 30.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/19/2016] [Revised: 11/04/2016] [Accepted: 11/10/2016] [Indexed: 12/13/2022]
|
24
|
Affiliation(s)
- Tetsuji Orita
- Department of Neurosurgery, Shuto General HospitalKogaisaku 1000-1, Yanai, Yamaguchi 742, Japan
| | - Akifumi Szumihara
- Department of Neurosurgery, Shuto General HospitalKogaisaku 1000-1, Yanai, Yamaguchi 742, Japan
| | - Tohru Tsurutani
- Department of Neurosurgery, Shuto General HospitalKogaisaku 1000-1, Yanai, Yamaguchi 742, Japan
| | - Koji Kajiwara
- Department of Neurosurgery, Shuto General HospitalKogaisaku 1000-1, Yanai, Yamaguchi 742, Japan
| |
Collapse
|
25
|
Ideguchi M, Kajiwara K, Yoshikawa K, Goto H, Sugimoto K, Inoue T, Nomura S, Suzuki M. Avoidance of ischemic complications after resection of a brain lesion based on intraoperative real-time recognition of the vasculature using laser speckle flow imaging. J Neurosurg 2016; 126:274-280. [PMID: 27035176 DOI: 10.3171/2016.1.jns152067] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECTIVE To avoid ischemic complications, it is important to consider the arteries in resection planning for lesions such as a vascular intraparenchymal tumor and arteriovenous malformation. Here, the clinical application of laser speckle flow imaging (LSFI) as a complementary method for the management of mass lesion-related arteries during surgery was evaluated. METHODS LSFI was performed in 12 patients with mass lesion-related arteries and brain tumor or arteriovenous malformation. The portable LSFI device was centered over the surgical field, and the relative cerebral blood flow (CBF) before and after the temporary interruption of the arteries was measured through continuous recording. CBF fluctuations permitted the classification of 3 kinds of artery-a feeding artery (FA), a "passing through" artery (PA), and a combined FA and PA (FA+PA)-based on decreased relative CBF in the inner resection area and unchanged CBF in the surrounding area (FA), unchanged CBF in the inner area and decreased CBF in the surrounding area (PA), or decreased CBF in both areas (FA+PA). This information allowed the appropriate management of these arteries and avoidance of postoperative ischemic complications. RESULTS Good visualization of CBF in the surgical field and relative CBF measurements in the regions of interest were achieved in real time with excellent spatiotemporal resolution. In 11 patients (92%) and 20 regions of interest, a decline in CBF was observed after temporary interruption of the FA (n = 8), PA (n = 2), and FA+PA (n = 2) types. There was a significant average reduction in CBF of 15.3% ± 29.0%. There were no ischemic complications, and only 1 patient had a postoperative ischemic lesion caused by resection through an artery that could not be viewed by LSFI due to a positional problem. CONCLUSIONS LSFI permits noninvasive and rapid intraoperative real-time recognition of mass lesion-related vasculature. This information can be used to avoid ischemic complications as a procedure complementary to neurophysiological monitoring.
Collapse
Affiliation(s)
- Makoto Ideguchi
- Department of Neurosurgery, Yamaguchi University Graduate School of Medicine; and
| | - Koji Kajiwara
- Department of Neurosurgery, Ube-nishi Rehabilitation Hospital, Ube, Japan
| | - Koichi Yoshikawa
- Department of Neurosurgery, Yamaguchi University Graduate School of Medicine; and
| | - Hisaharu Goto
- Department of Neurosurgery, Yamaguchi University Graduate School of Medicine; and
| | - Kazutaka Sugimoto
- Department of Neurosurgery, Yamaguchi University Graduate School of Medicine; and
| | - Takao Inoue
- Department of Neurosurgery, Yamaguchi University Graduate School of Medicine; and
| | - Sadahiro Nomura
- Department of Neurosurgery, Yamaguchi University Graduate School of Medicine; and
| | - Michiyasu Suzuki
- Department of Neurosurgery, Yamaguchi University Graduate School of Medicine; and
| |
Collapse
|
26
|
Kajiwara K, Matsui Y, Yadav TP, Mukhopadhyay NK, Srivastava ON. Quasicrystal as a Catalyst for the Synthesis of Carbon Nanotubes. J Nanosci Nanotechnol 2016; 16:3084-3089. [PMID: 27455765 DOI: 10.1166/jnn.2016.12468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
The present report describes the catalytic activity of mechanically activated nano quasicrystalline Al65Cu20Fe15 and related nano crystalline Al50Cu28Fe22 for the synthesis of carbon nanotubes (CNTs). CNTs are synthesized by catalytic decomposition of ethanol through nano quasicrystalline Al65Cu20Fe15 and related crystalline Al50Cu28Fe22 alloys as a catalyst. The synthesized multi-walled CNTs exhibits tube diameter ranging from 5 to 25 nm. The synthesized CNTs are characterized by scanning and transmission electron microscopy. It is found that Al65Cu20Fe15 nanoquasicystal shows better catalytic behaviour as compared to nano-crystalline Al50Cu28Fe22 alloys for decomposition of ethanol during the synthesis of multi-walled CNTs.
Collapse
|
27
|
Sugimoto K, Ideguchi M, Kimura T, Kajiwara K, Imoto H, Sadahiro H, Ishii A, Kawano H, Ikeda E, Suzuki M. Epithelioid/rhabdoid glioblastoma: a highly aggressive subtype of glioblastoma. Brain Tumor Pathol 2015; 33:137-46. [DOI: 10.1007/s10014-015-0243-3] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2015] [Accepted: 11/29/2015] [Indexed: 11/28/2022]
|
28
|
Kojima A, Harada S, Hirano M, Hayashi H, Tamogami H, Iwama K, Kajiwara K, Kozai Y, Kodo H. 303P The diagnostic splenectomy: a review of 12 years' experience of the procedure at our institution. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv526.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
29
|
Takahashi K, Abe G, Kajiwara K, Oda Y, Isozaki M, Ikeda R, Sakamoto K, Omori T, Henderson M. Design modification of ITER equatorial EC launcher for electron cyclotron heating and current drive optimization. Fusion Engineering and Design 2015. [DOI: 10.1016/j.fusengdes.2015.04.058] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
30
|
Aoyama K, Ota Y, Uchibori M, Aoki T, Kajiwara K, Kimura M. 2810 NOTCH1 mutations found in Japanese oral carcinoma. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31553-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
31
|
Jeong JH, Bae YS, Joung M, Kim D, Goodman TP, Sauter O, Sakamoto K, Kajiwara K, Oda Y, Kwak JG, Namkung W, Cho MH, Park H, Hosea J, Ellis R. Demonstration of sawtooth period control with EC waves in KSTAR plasma. EPJ Web of Conferences 2015. [DOI: 10.1051/epjconf/20158702016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
32
|
Yamanaka R, Kawaguchi A, Iwadate Y, Komohara Y, Kajiwara K, Fujii Y. Gene Expression Signature–Based Prognostic Risk Score in Patients with Primary Central Nervous System Lymphoma. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu435.62] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
33
|
Inoue Y, Kokuba Y, Katsura T, Fujimaki M, Kajiwara K. PP227-MON: Can Lipid Emulsion be Administered as Secondary Piggyback Infusion Through Primary TPN Infusion Line? – Studies for the Changes of Lipid Particle Size. Clin Nutr 2014. [DOI: 10.1016/s0261-5614(14)50561-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
34
|
Kajiwara K, Takahashi K, Oda Y, Kobayashi N, Sakamoto K. Optimization of millimeter wave system in ITER Equatorial EC H&CD Launcher. Fusion Engineering and Design 2014. [DOI: 10.1016/j.fusengdes.2013.10.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
35
|
Ideguchi M, Kajiwara K, Yoshikawa K, Sadahiro H, Nomura S, Fujii M, Suzuki M. Characteristics of intraoperative abnormal hemodynamics during resection of an intra-fourth ventricular tumor located on the dorsal medulla oblongata. Neurol Med Chir (Tokyo) 2013; 53:655-62. [PMID: 24077276 PMCID: PMC4508747 DOI: 10.2176/nmc.oa2012-0401] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Abnormal hemodynamics during extirpation of a para-medulla oblongata (MO) tumor is common and may be associated with direct vagal stimulation of the medullary circuit. However, resection of tumors on the dorsal MO may also induce hemodynamic instability without direct vagal stimulus. The objective of this study was to examine the characteristics of hemodynamic instability unrelated to vagal stimulus during dissection of an intra-fourth ventricular tumor with attachment to the dorsal MO. A retrospective analysis was performed in 13 patients. Abnormal hemodynamics were defined as a > 20% change from the means of the intraoperative mean arterial pressure (MAP) and heart rate (HR). Relationships of intraoperative hemodynamics were evaluated with various parameters, including the volume of the MO. Six patients (46.2%) had intraoperative hypertension during separation of the tumor bulk from the dorsal MO. The maximum MAP and HR in these patients were significantly greater than those in patients with normal hemodynamics (116.0 ± 18.0 mmHg versus 85.6 ± 6.5 mmHg; 124.3 ± 22.8 bpm versus 90.5 ± 14.7 bpm). All six cases with abnormal hemodynamics showed hemodynamic fluctuation during separation of the tumor bulk from the dorsal MO. The preoperative volume of the MO in these patients was 1.11 cc less than that in patients with normal hemodynamics, but the volume after tumor resection was similar in the two groups (5.23 cc and 5.12 cc). This suggests that the MO was compressed by the conglutinate tumor bulk, with resultant fluctuation of hemodynamics. Recognition of and preparation for this phenomenon are important for surgery on a tumor located on the dorsal MO.
Collapse
Affiliation(s)
- Makoto Ideguchi
- Department of Neurosurgery, Yamaguchi University Graduate School of Medicine
| | | | | | | | | | | | | |
Collapse
|
36
|
Shinoyama M, Ideguchi M, Kida H, Kajiwara K, Kagawa Y, Maeda Y, Nomura S, Suzuki M. Cortical region-specific engraftment of embryonic stem cell-derived neural progenitor cells restores axonal sprouting to a subcortical target and achieves motor functional recovery in a mouse model of neonatal hypoxic-ischemic brain injury. Front Cell Neurosci 2013; 7:128. [PMID: 23970853 PMCID: PMC3748369 DOI: 10.3389/fncel.2013.00128] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2013] [Accepted: 07/25/2013] [Indexed: 01/14/2023] Open
Abstract
Hypoxic-ischemic encephalopathy (HIE) at birth could cause cerebral palsy (CP), mental retardation, and epilepsy, which last throughout the individual's lifetime. However, few restorative treatments for ischemic tissue are currently available. Cell replacement therapy offers the potential to rescue brain damage caused by HI and to restore motor function. In the present study, we evaluated the ability of embryonic stem cell-derived neural progenitor cells (ES-NPCs) to become cortical deep layer neurons, to restore the neural network, and to repair brain damage in an HIE mouse model. ES cells stably expressing the reporter gene GFP are induced to a neural precursor state by stromal cell co-culture. Forty-hours after the induction of HIE, animals were grafted with ES-NPCs targeting the deep layer of the motor cortex in the ischemic brain. Motor function was evaluated 3 weeks after transplantation. Immunohistochemistry and neuroanatomical tracing with GFP were used to analyze neuronal differentiation and axonal sprouting. ES-NPCs could differentiate to cortical neurons with pyramidal morphology and expressed the deep layer-specific marker, Ctip2. The graft showed good survival and an appropriate innervation pattern via axonal sprouting from engrafted cells in the ischemic brain. The motor functions of the transplanted HIE mice also improved significantly compared to the sham-transplanted group. These findings suggest that cortical region specific engraftment of preconditioned cortical precursor cells could support motor functional recovery in the HIE model. It is not clear whether this is a direct effect of the engrafted cells or due to neurotrophic factors produced by these cells. These results suggest that cortical region-specific NPC engraftment is a promising therapeutic approach for brain repair.
Collapse
Affiliation(s)
- Mizuya Shinoyama
- Department of Neurosurgery, Yamaguchi University School of Medicine Ube, Japan
| | | | | | | | | | | | | | | |
Collapse
|
37
|
Inoue T, Arasaki O, Kawamitsu K, Kajiwara K, Shinzato Y, Ishikawa N, Yamamoto A, Sunagawa O, Katsumata Y, Ueda S. Impact of beta-blockers and resting heart rate in diabetic patients with stable coronary artery disease. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht308.p2482] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Kajiwara K, Saito KI, Yoshikawa K, Ideguchi M, Nomura S, Fujii M, Suzuki M. Stereotactic radiosurgery/radiotherapy for pituitary adenomas: a review of recent literature. Neurol Med Chir (Tokyo) 2013; 50:749-55. [PMID: 20885109 DOI: 10.2176/nmc.50.749] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The recent clinical results are reviewed of stereotactic radiosurgery/radiotherapy for the treatment of pituitary adenomas. The outcomes of pituitary adenomas treated by stereotactic radiosurgery/radiotherapy with gamma knife, CyberKnife, or linear accelerator (LINAC) radiosurgery were evaluated from articles published after 2004. Each study was evaluated for the number of patients, radiosurgical parameter (marginal dose), length of follow up, tumor growth control, rate of hormonal normalization in secretary adenomas, and adverse events. After gamma knife radiosurgery, the tumor reduction rates varied from 42.3% to 89% in non-secreting adenomas. However, the tumor control rates in non-secreting adenomas were more than 90% in most studies. In growth hormone-secreting adenomas, the rates of insulin-like growth factor-1 normalization ranged from 36.9% to 82%. In adrenocorticotropin-secreting adenomas, the rates for 24-hour urine free cortisol normalization ranged from 27.9% to 54%. In prolactin-secreting adenomas, the prolactin normalization ranged from 17.4% to 50%. New hormonal deficits ranged from 0% to 34%. New visual deficits were relatively low. The number of patients treated with CyberKnife and LINAC radiosurgery/radiotherapy was small and follow-up periods were relatively short compared to those with gamma knife treatment, but the clinical outcomes after these therapies were similar to those after gamma knife therapy. Image-guided stereotactic radiosurgery/radiotherapy with the gamma knife, CyberKnife, or LINAC system is effective and safe against pituitary adenomas. Careful long-term follow up of the patients is necessary because of long-term anti-tumor effects and delayed adverse events.
Collapse
Affiliation(s)
- Koji Kajiwara
- Department of Neurosurgery, Yamaguchi University School of Medicine, Minsami-kogushi, Yamaguchi, Japan.
| | | | | | | | | | | | | |
Collapse
|
39
|
Nishizaki T, Sasaki K, Murakami T, Matsumura K, Orita T, Kajiwara K, Aoki H. Double Fixation with Paraformaldehyde and Acetone for Optimal Immunocytochemical Demonstration of DNA Polymerase α. J Histotechnol 2013. [DOI: 10.1179/his.1989.12.4.285] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
40
|
Jeong J, Bae Y, Joung M, Kim H, Park S, Han W, Kim J, Yang H, Kwak J, Sakamoto K, Kajiwara K, Oda Y, Hayashi K. Development of high voltage power supply for the KSTAR 170 GHz ECH and CD system. Fusion Engineering and Design 2013. [DOI: 10.1016/j.fusengdes.2013.03.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
41
|
Takahashi K, Iida H, Abe T, Kobayashi N, Kajiwara K, Sakamoto K, Omori T, Henderson M. Nuclear Analysis of ITER Equatorial EC Launcher. Fusion Science and Technology 2013. [DOI: 10.13182/fst13-a16894] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- K. Takahashi
- Japan Atomic Energy Agency, 801-1, Mukoyama, Naka, Ibaraki-ken 311-0193, Japan
| | - H. Iida
- Nippon Advanced Technology Co. LTD, Ibaraki-ken, Tokai, 319-1112, Japan
| | - T. Abe
- Japan Computer System Co. LTD, Ibaraki-ken, Mito, 310-0805, Japan
| | - N. Kobayashi
- Nippon Advanced Technology Co. LTD, Ibaraki-ken, Tokai, 319-1112, Japan
| | - K. Kajiwara
- Japan Atomic Energy Agency, 801-1, Mukoyama, Naka, Ibaraki-ken 311-0193, Japan
| | - K. Sakamoto
- Japan Atomic Energy Agency, 801-1, Mukoyama, Naka, Ibaraki-ken 311-0193, Japan
| | - T. Omori
- ITER Organization, Route de Vinon sur Verdon, 13115 St. Paul lez Durance, France
| | - M. Henderson
- ITER Organization, Route de Vinon sur Verdon, 13115 St. Paul lez Durance, France
| |
Collapse
|
42
|
Goto H, Suzuki M, Akimura T, Fujisawa H, Yoneda H, Oka F, Nomura S, Kajiwara K, Kato S, Fujii M. Progression of stenosis into occlusion of the distal posterior cerebral artery supplying an occipital arteriovenous malformation manifesting as multiple ischemic attacks: case report. Neurol Med Chir (Tokyo) 2012; 52:899-902. [PMID: 23269045 DOI: 10.2176/nmc.52.899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
A 31-year-old healthy male presented with a rare case of cerebral arteriovenous malformation (AVM) manifesting as repeated ischemic attacks and cerebral infarction causing left sensori-motor disturbance. Neuroimaging revealed cerebral infarction in the right thalamus as well as right occipital AVM without bleeding. The AVM was mainly fed by the right angular artery, and the right posterior cerebral artery (PCA) showed mild stenosis and segmental dilation at the P(2)-P(3) portion. After referral to our hospital, transient ischemic attacks causing left homonymous hemianopsia, and left arm and leg numbness were frequently recognized. Additional imaging revealed a new ischemic lesion in the occipital lobe, and repeated cerebral angiography showed right PCA occlusion at the P(2)-P(3) segment. Cerebral AVM presenting with cerebral infarction due to occlusion of feeding arteries is rare. In our case, intimal injury due to increased blood flow or spontaneous dissection of the artery were possible causes. We should monitor any changes in the architecture and rheology of the feeding vessels during the clinical course to prevent ischemic complications.
Collapse
Affiliation(s)
- Hisaharu Goto
- Department of Neurosurgery, Yamaguchi University School of Medicine, Ube, Yamaguchi.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Oda Y, Kajiwara K, Takahashi K, Sakamoto K. Development of dual frequency gyrotron and high power test of EC components. EPJ Web of Conferences 2012. [DOI: 10.1051/epjconf/20123204004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
44
|
Fujii M, Inoue T, Sadahiro H, Yoshikawa K, Ideguchi M, Nomura S, Kajiwara K, Yamakawa T, Suzuki M. 13. Development of a functional mapping method using focal cortical cooling in awake craniotomy. Clin Neurophysiol 2012. [DOI: 10.1016/j.clinph.2012.02.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
45
|
Kawaguchi A, Iwadate Y, Komohara Y, Sano M, Kajiwara K, Yajima N, Tsuchiya N, Homma J, Aoki H, Kobayashi T, Sakai Y, Hondoh H, Fujii Y, Kakuma T, Yamanaka R. Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma. Clin Cancer Res 2012; 18:5672-81. [PMID: 22908096 DOI: 10.1158/1078-0432.ccr-12-0596] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
PURPOSE Better understanding of the underlying biology of primary central nervous system lymphomas (PCNSL) is critical for the development of early detection strategies, molecular markers, and new therapeutics. This study aimed to define genes associated with survival of patients with PCNSL. EXPERIMENTAL DESIGN Expression profiling was conducted on 32 PCNSLs. A gene classifier was developed using the random survival forests model. On the basis of this, prognosis prediction score (PPS) using immunohistochemical analysis is also developed and validated in another data set with 43 PCNSLs. RESULTS We identified 23 genes in which expressions were strongly and consistently related to patient survival. A PPS was developed for overall survival (OS) using a univariate Cox model. Survival analyses using the selected 23-gene classifiers revealed a prognostic value for high-dose methotrexate (HD-MTX) and HD-MTX-containing polychemotherapy regimen-treated patients. Patients predicted to have good outcomes by the PPS showed significantly longer survival than those with poor predicted outcomes (P < 0.0001). PPS using immunohistochemical analysis is also significant in test (P = 0.0004) and validation data set (P = 0.0281). The gene-based predictor was an independent prognostic factor in a multivariate model that included clinical risk stratification (P < 0.0001). Among the genes, BRCA1 protein expressions were most strongly associated with patient survival. CONCLUSION We have identified gene expression signatures that can accurately predict survival in patients with PCNSL. These predictive genes should be useful as molecular biomarkers and they could provide novel targets for therapeutic interventions.
Collapse
|
46
|
Shiraishi N, Kitamura K, Hayata M, Ogata T, Adachi M, Kajiwara K, Ikeda H, Miyoshi T, Tomita K. Case of anti-glomerular basement membrane antibody-induced glomerulonephritis with cytomegalovirus-induced thrombotic microangiopathy. Intern Med J 2012; 42:e7-e11. [PMID: 22432999 DOI: 10.1111/j.1445-5994.2011.02703.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Although the involvement of cytomegalovirus (CMV) infections in the development of thrombotic microangiopathy (TMA) in HIV patients and transplant recipients has been reported, it is still controversial whether CMV itself can cause TMA. We report herein a rare case with rapid improvement of TMA by ganciclovir treatment in a patient who is neither HIV-positive nor a transplant recipient, suggesting a pathogenic role for CMV in TMA.
Collapse
Affiliation(s)
- N Shiraishi
- Department of Nephrology, Kumamoto University Graduate School of Life Sciences, Kumamoto, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Yasuda H, Nagira T, Yoshiya M, Sugiyama A, Nakatsuka N, Kiire M, Uesugi M, Uesugi K, Umetani K, Kajiwara K. Massive transformation fromδphase toγphase in Fe–C alloys and strain induced in solidifying shell. ACTA ACUST UNITED AC 2012. [DOI: 10.1088/1757-899x/33/1/012036] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
48
|
Komohara Y, Horlad H, Ohnishi K, Ohta K, Makino K, Hondo H, Yamanaka R, Kajiwara K, Saito T, Kuratsu JI, Takeya M. M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma. ACTA ACUST UNITED AC 2012; 51:93-9. [PMID: 22104307 DOI: 10.3960/jslrt.51.93] [Citation(s) in RCA: 57] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
Abstract
Primary central nervous system lymphoma (PCNSL) is one of the most aggressive malignant lymphomas with a median survival of less than 20~40 months. Interest in signal transducer and activator of transcription 3 (Stat3) has increased during the past decade because Stat3 activation was found to contribute to tumor progression by inducing angiogenesis, immunosuppression, and metastasis. We previously demonstrated a significant correlation between Stat3 activation in tumor cells and infiltrating anti-inflammatory (M2) macrophages. Here, we focused on the phenotypes of infiltrating macrophages/microglial cells and Stat3 activation in PCNSL cells. The correlation of Stat3 activation or density of M2 macrophage infiltration with patient prognosis was also evaluated. We performed immunostaining for CD68, CD163, CD204, and pStat3 using paraffin-embedded PCNSL specimens obtained from 43 patients. CD163 and CD204 served as markers of the M2 phenotype. Dense infiltration of CD68(+) macrophages was found in all samples. High numbers of CD163(+) and CD204(+) M2 macrophages/microglial cells were observed in 29 and 25 cases, respectively. Stat3 activation in lymphoma cells was enhanced in the patients who showed denser infiltration of CD163(+) macrophages/microglial cells in tumor tissues. In vitro co-culture experiment to investigate cell-cell interactions between macrophages and lymphoma cells found that Stat3 in lymphoma cells was strongly activated by co-culture with macrophages. Numbers of CD68(+), CD163(+), and CD204(+) tumor-associated macrophages/microglial cells (TAMs) and Stat3 activation in lymphoma cells were not correlated with prognosis. However, because Stat3 involvement in tumor development was demonstrated in several malignant tumors, our present finding that cell-cell interactions of M2 macrophage/microglial cells with lymphoma cells induced Stat3 activation may provide novel insights into PCNSL pathogenesis.
Collapse
Affiliation(s)
- Yoshihiro Komohara
- Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Maruta Y, Fujii M, Imoto H, Nomura S, Oka F, Goto H, Shirao S, Yoshikawa K, Yoneda H, Ideguchi M, Suehiro E, Koizumi H, Ishihara H, Kato S, Kajiwara K, Suzuki M. Intra-operative monitoring of lower extremity motor-evoked potentials by direct cortical stimulation. Clin Neurophysiol 2012; 123:1248-54. [PMID: 22104472 DOI: 10.1016/j.clinph.2011.09.025] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2011] [Revised: 09/09/2011] [Accepted: 09/30/2011] [Indexed: 10/15/2022]
|
50
|
Miyata K, Hayakawa S, Kajiwara K, Kanno H. Supercooling and vitrification of aqueous glycerol solutions at normal and high pressures. Cryobiology 2012; 65:113-6. [PMID: 22609515 DOI: 10.1016/j.cryobiol.2012.05.002] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2012] [Revised: 04/18/2012] [Accepted: 05/02/2012] [Indexed: 10/28/2022]
Abstract
The supercooling and vitrification of aqueous glycerol solutions was studied at high pressures. Homogeneous ice nucleation temperatures (T(H)) were obtained for aqueous glycerol solutions of R=50, 30, 20, 12, and 10 (R: moles of water/moles of glycerol) up to 300MPa. The R=20 glycerol solution formed a glass above 200MPa at a cooling rate of 200°C/min, indicating that pressure enhances glass-formation of aqueous glycerol solutions. The (dT(g)/dP) values were obtained for vitrified aqueous glycerol solutions of R=3, 5, 10, and 20. These data can be used for the development of cryo-preservation liquids for living cells at high pressures.
Collapse
Affiliation(s)
- K Miyata
- Department of Applied Chemistry, National Defense Academy, Yokosuka 239-8686, Japan
| | | | | | | |
Collapse
|